Rockwell Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	9.61	10.71	15.66	8.98	10.1	13.28
Short-Term Investments	14.28	14.29	5.94	1.95	11.39	9.16
Cash & Short-Term Investments	23.89	25	21.6	10.94	21.49	22.44
Cash Growth	37.84%	15.72%	97.55%	-49.12%	-4.22%	-61.76%
Accounts Receivable	8.83	8.14	8.29	10.9	6.26	5.91
Inventory	3.06	3.42	5.78	5.87	5.81	4.08
Other Current Assets	1.17	1.6	1.36	1.06	1.75	2.86
Total Current Assets	36.94	38.16	37.03	28.77	35.31	35.29
Net Property, Plant & Equipment	9.49	7.85	10.34	11.02	8.61	10.22
Other Intangible Assets	9.52	9.66	10.21	10.76	-	-
Goodwill	0.92	0.92	0.92	0.92	0.92	0.92
Other Long-Term Assets	0.56	0.56	0.71	0.71	1.8	2.14
Total Assets	57.42	57.15	59.21	52.17	46.64	48.57
Accounts Payable	3.45	2	2.87	4.52	4.05	3.74
Accrued Expenses	3.16	4.34	6.28	7.15	7.7	5.09
Short-Term Debt	0.07	0.26	0.27	0.24	0.5	0.44
Current Portion of Long-Term Debt	0.71	-	-	-	1.63	7.38
Current Portion of Leases	1.92	1.62	2.17	1.94	2.01	2
Unearned Revenue	-	-	0.05	0.05	1.73	2.17
Other Current Liabilities	0.57	1.36	2.47	2.74	0.07	0.14
Total Current Liabilities	9.87	9.58	14.09	16.64	17.69	20.97
Long-Term Debt	8.91	8.83	8.47	8.29	9.19	20.57
Long-Term Leases	3.49	1.76	2.63	2.96	4.67	5.89
Other Long-Term Liabilities	-	-	1.43	2.99	2.61	6
Total Long-Term Liabilities	12.41	10.58	12.53	14.25	16.47	32.45
Total Liabilities	21.57	20.16	26.62	30.88	32.53	46.04
Preferred Stock	-	-	-	-	0	0
Common Stock	0	0	0	0	402.7	0
Additional Paid-in Capital	440.32	439.84	430.21	418.49	-388.76	372.56
Accumulated Other Comprehensive Income	0.13	0.13	0.05	-0	-	0.05
Retained Earnings	-404.6	-402.99	-397.68	-397.2	0.16	-370.08
Shareholders' Equity	35.86	36.98	32.59	21.29	14.11	2.54
Total Liabilities & Equity	57.42	57.15	59.21	52.17	46.64	48.57
Total Debt	15.1	12.47	13.54	13.44	17.99	36.28
Net Cash (Debt)	8.79	12.53	8.07	-2.5	3.5	-13.84
Net Cash Growth	-29.80%	55.26%	-	-	-	-
Net Cash Per Share	2.36	3.48	2.60	-1.07	2.44	-16.23
Book Value	35.86	36.98	32.59	21.29	14.11	2.54
Book Value Per Share	9.62	10.28	10.49	9.13	9.86	2.97
Tangible Book Value	25.42	26.4	21.46	9.61	13.19	1.61
Tangible Book Value Per Share	6.82	7.34	6.91	4.12	9.22	1.89

SEC Filings: 10-K · 10-Q